AOAC 2019 | Annual Meeting & Exposition, Denver, US, 6-12/9/2019

Prognosis-Biotech-in-AOAC-2019-1

ProGnosis Biotech participated in AOAC INTERNATIONAL Annual Meeting in Denver, US (6-12 September).

The Co-founder and Managing Director of ProGnosis Biotech Mr. Antonios Ntantasios and the Co-founder & C.O.O Mr. Georgios Papageorgiou attended the event, presenting in the meeting’s posters session our company’s new methods and technologies regarding the detection and measurement of food natural toxins and food allergens. Specifically, our delegates presented five methods that provide innovative solutions for the quantitative determination of Mycotoxins and Histamine in food/feed and sea food samples respectively.

The feedback we received from the academia and the industry was very positive and we look forward to developing in the future more innovative methods than can benefit the food safety sector.

www.aoac.org

Share This Post

More To Explore